BlueGnome was founded in in 2002 by a team of scientists who developed a novel mathematical technology for the analysis of genetic data following the sequencing of the human genome in 2000. Over the following 10 years BlueGnome has seen rapid growth and adoption of its technology and has become a leading provider of genetic solutions for the screening of chromosomal abnormalities in cytogenetics and IVF. This year BlueGnome was acquired by Illumina and is now a wholly owned subsidiary of Illumina - enhancing the company's ability to establish integrated solutions in reproductive health and cancer. Below is a timeline of BlueGnome's milestones to date.